FDA: CBD shouldn’t be a controlled substance, but treaties require it
The U.S. Food and Drug Administration noted that cannabidiol shouldn’t be a controlled substance, but international treaties require the United States to treat it as one. That revelation from the federal agency said in a 27-page memo written after it approved the first drug made with CBD earlier this year. “CBD has negligible... Read more
What Farm Bill? Hemp industry shrugs off law’s expiration
The law that ushered in the modern hemp industry in the United States has expired, but hemp growers, processors and retailers are counting on legal assurances that the nation’s experiment in allowing limited hemp production won’t immediately end. The 2014 Farm Bill, which authorized hemp production under state research... Read more
Australian CBD maker raises $29 million, ups investment in Japan
Australian CBD company Elixinol Global raised $40 million Australian dollars ($29 million) in a new share placement to ramp up sales and marketing efforts in the United States and Europe. The capital raise comes less than a week after the company announced its wholly owned subsidiary, EXL International Holdings, increased its... Read more
Committee Blog: Progression in Packaging – Challenges & Opportunities for Cannabis Brands
by NCIA’s Packaging and Labeling CommitteeLisa Hansen, Plaid Cannabiz Marketing and Brian Smith, Satori Wellness Exciting Times Any visit to a licensed dispensary is proof of how far we’ve come with the packaging of legal cannabis. Sure, we still have plenty of standard glass jars, CR pouches, pop-tops and... Read more
DEA takes CBD off Schedule 1 – with FDA’s approval
The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1%... Read more
Multistate medical marijuana operators tapped for Virginia’s CBD program
Virginia named its first five CBD-only medical cannabis business licensees – three of them multistate operators. Virginia’s Board of Pharmacy reviewed 51 applicants to produce CBD products in five areas of the state. The winning applicants are called “pharmaceutical processors” and must grow, process and sell the products at one location,... Read more
Committee Blog: How can we help your cannabis business?
What can we provide that can help you in your cannabis business?  NCIA’s member-driven Marketing & Advertising Committee is focused on developing best practices in cannabis industry marketing; opening dialogues with major media outlets that ban most or all cannabis-related advertising; holding in-person or virtual educational events for NCIA... Read more
Member Blog: How Much Does it Actually Cost to Open a Dispensary?
by Gary Cohen, Cova Software Reading headlines about the cannabis industry, one might get the impression that cannabis business owners are all cashing out big. And while there are many success stories, high startup costs, ranging between $250,000 to $750,000, make the financial reality of opening a dispensary difficult... Read more
Appropriations and Cannabis (Part 2): Why It Matters
by Michelle Rutter, NCIA Government Relations Manager Last week, we explained the appropriations process and detailed how Congress allocates federal funds (click here for a quick refresh). This week, we’ll take a look at how exactly cannabis fits into the equation, and why it matters. By 2001, California, Oregon,... Read more
Hemp Notebook: What the railroad industry can teach today’s hemp businesses
(This is an abridged version of a column that appears in the September issue of Marijuana Business Magazine.) Hemp is in an economic fast lane, with new ventures starting every day. So, it may seem odd to say modern entrepreneurs should consider 19th century railroads. But those railroad magnates faced... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )